Vitae Pharmaceuticals, Inc.
Q2 2015 13F Holders
Symbol
VTAE
CUSIP
92847N103
Type
Equity
Class
COM
Num filings
53
Total reported value, excl. options
$193 M
Compare 2015 Q2 to
2016 Q3
2016 Q2
2016 Q1
2015 Q4
2015 Q3
2015 Q1
2014 Q4
2014 Q3
Manager
Report Date
Value ($000)
Shares
Option Type